Use of aggregating cell cultures for toxicological studies.
Relatively simple techniques are now available which allow the preparation of large quantities of highly reproducible aggregate cultures from fetal rat brain or liver cells, and to grow them in a chemically defined medium. Since these cultures exhibit extensive histotypic cellular reorganization and maturation, they offer unique possibilities for developmental studies. Therefore, the purpose of the present study was to investigate the usefulness of these cultures in developmental toxicology. Aggregating brain cell cultures were exposed at different developmental stages to model drugs (i.e., antimitotic, neurotoxic, and teratogenic agents) and assayed for their responsiveness by measuring a set of biochemical parameters (i.e., total protein and DNA content, cell type-specific enzyme activities) which permit a monitoring of cellular growth and maturation. It was found that each test compound elicited a distinct, dose-dependent response pattern, which may ultimately serve to screen and classify toxic drugs by using mechanistic criteria. In addition, it could be shown that aggregating liver cell cultures are capable of toxic drug activation, and that they can be used in co-culture with brain cell aggregates, providing a potential model for complementary toxicological and metabolic studies.
D000818:Animals; D001711:Biotransformation; D001921:Brain / Q000187:drug effects / Q000196:embryology / Q000254:growth & development* / Q000378:metabolism; D002449:Cell Aggregation; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D002772:Cholera Toxin / Q000494:pharmacology / Q000633:toxicity; D003561:Cytarabine / Q000494:pharmacology / Q000633:toxicity; D064420:Drug-Related Side Effects and Adverse Reactions; D009186:Myelin Sheath / Q000187:drug effects / Q000502:physiology; D051381:Rats; D011919:Rats, Inbred Strains; D013936:Thymidine / Q000494:pharmacology / Q000633:toxicity; D015091:beta-Alanine / Q000031:analogs & derivatives / Q000494:pharmacology / Q000633:toxicity
D003561:Cytarabine; D015091:beta-Alanine; C011757:2,3-diaminopropionic acid; D002772:Cholera Toxin; D013936:Thymidine